Advertisement

First batch of China's CanSino vaccines against Covid arrive in Pakistan

Follow The Hawk on Google News+ Follow

Advertisement


Islamabad: The first batch of CanSino Covid-19 vaccines that the Pakistani government purchased from China arrived here on Tuesday night.

Earlier, the third phase trials of the CanSino vaccine had been conducted in Pakistan and it is the second Chinese Covid-19 vaccine that Pakistan approved for emergency use in the country, the Xinhua news agency reported.

Advertisement

The CanSino Biologics Inc. said that the single-dose CanSino Covid-19 vaccine is expected to facilitate the building of immunity in the Pakistani society to help the country restore the normal functioning of society and economy.

Also readFSSAI to initiate action against Bisleri over unsafe water sample

In February, Special Assistant to the Pakistani Prime Minister on Health Faisal Sultan said that the third phase trials of the CanSino vaccine showed that it is 74.8 per cent efficient in preventing symptomatic cases of Covid-19 in the country.

Sharing results of the trials in Pakistan on social media, Sultan said that the Covid-19 vaccine proved 100 per cent efficient at preventing severe disease in Pakistan.

Advertisement

Sultan further said that the interim analysis by an independent data monitoring committee also said that the vaccine showed 65.7 per cent efficacy at preventing symptomatic cases and 90.98 per cent at preventing severe disease in multi-country analysis, adding that the committee did not report any serious safety concerns regarding the vaccine.

Also read'Fatty liver-free campaign' in Ranchi from Nov 23, MoS Sanjay Seth to take lead

Currently, Pakistan is facing a third wave of Covid-19 and the positivity rate has seen a sharp rise, forcing the Pakistani authorities to continue tightening the anti-pandemic measures including banning public gatherings across the country.

A total of 4,084 new Covid-19 cases were reported in Pakistan during the last 24 hours, taking the tally to 663,200 out of which 14,356 died and 600,278 recovered, according to the data released by the country's health ministry on Tuesday.

--IANS

Get The Hawk first on Google

Add The Hawk as a preferred source and Google shows you more of our stories in Top Stories. Follow us on Google News too.

Share this story

Advertisement

India eyes space-based drug development as scientists, startups explore microgravity researchRead next →India eyes space-based drug development as scientists, startups explore microgravity researchHealth · 22 Nov 2026, 03:08 PM IST